Measurements Before and After Participation in a Health Intervention Programme in Halsnaes Municipality
Effects for Individuals Following a Health Intervention Programme in Halsnaes Municipality; A Sub-project Under the Initiative: Quality Development in Community Healthcare: Steno Tvaers
Based on the Danish Health Authority's quality standards for municipal prevention services for citizens with chronic diseases, Steno Diabetes Center Copenhagen (SDCC), Halsnaes Municipality, North Zealand Hospital, and others have entered into a cross-sectoral collaboration entitled "Quality Development in Community Healthcare: Steno Tvaers - A Model for Differentiated Health Interventions for Citizens with Diabetes, Chronic Obstructive Pulmonary Disease (COPD), or Cardiovascular Disease sased in Halsnaes Municipality" (hereafter referred to as Steno Tvaers). Based in Halsnaes Municipality, the aim of Steno Tvaers is to adapt and, where relevant, supplement existing healthcare services in the municipality to better meet the needs of and reach all citizens with chronic diseases.
The present sub-project "Measurements before and after participation in a health intervention programme in Halsnaes Municipality" (hereafter referred to as the sub-project) is conducted within the framework of Steno Tvaers. The objective of the current sub-project is to assess whether citizens with diabetes, COPD, or cardiovascular disease, who participate in a health intervention programme in Halsnaes Municipality, improve their functional capacity.
For citizens with diabetes, the sub-project also aims to assess whether participation in the programme results in improved blood glucose concentration, blood pressure, and medical adherence.
The hypothesis of the sub-project is that the organizational changes planned within Steno Tvaers for successful implementation of the quality standards will lead to a resulting health effect at the individual level.
It is important to note that the healthcare interventions are existing services, the quality and uptake of which are being enhanced through the Steno Tvaers project, and that this does not involve testing a new intervention. Participation in the project therefore only involves contributing data that are already being collected by the municipality, supplemented by responses to two questionnaires. For citizens with diabetes, this is further supplemented with data on blood glucose (HbA1c), blood pressure, attendance at follow-up visits with general practitioners and in hospital settings, as well as adherence to prescribed medication. Data are collected at the beginning and at the end of a health intervention programme, and at the end of the project, the data will be linked to selected national registers.
研究概览
地位
详细说明
The study will recruit citizens who are offered a health programme provided by Halsnaes Municipality and invite all citizens who live up to the inclusion criteria in the project period (with inclusion of a maximum of 200 citizens). Thus, purposive sampling, where the study staff target people who represent a specific demographic for study participation, is used. Statistical considerations:
A power calculation based on WHODAS 2.0 shows that, using a two-sided paired t-test and aiming to detect a minimal clinically relevant difference of 3.0 points in functional ability (ΔSD = 9.1), with 90% power, the study requires complete data from 97 participants. Accounting for an expected dropout rate and/or missing data of 50%, the project needs to include 194 participants. A descriptive analysis of the study population's demographics will be conducted based on descriptive data from the municipality's electronic health record system, national registers, and information from citizen interviews and questionnaire responses, in order to characterize the participant population.
To examine whether the organizational changes planned in Steno Tvaers lead to more citizens participating in and being retained in a municipal health programme, the uptake in the subproject population with the current uptake in the municipality will be compared.
To examine whether the organizational changes lead to downstream health effects at the individual level, differences in functional ability (muscle strength, well-being, health-related quality of life, as well as WHODAS-assessed functioning and disability) from the start to the end of a municipal health programme will be analyzed. Similarly, changes in blood glucose and blood pressure among citizens with diabetes will be analyzed. Changes in medical adherence (attendance and medication use) among citizens with diabetes will be measured as the number of annual check-ups each citizen attends, as well as the proportion of prescriptions redeemed relative to the number prescribed between baseline and end of the health programme.
Multiple linear regression (linear mixed models) will be used to analyze these changes over time (as there is no control group, only changes over time can be analyzed), including relevant covariates such as sociodemographic and health-related data from registers. Stratified analyses based on sociodemographic and health-related strata will also be conducted if relevant. The primary analyses will be performed after completion of the subproject but will also be conducted midway through the subproject period for those citizens who have completed a health programme by that time, although without linkage to national registers. Researchers from SDCC will assist with analyses and interpretation.
研究类型
注册 (估计的)
联系人和位置
学习联系方式
- 姓名:Stine V Hansen
- 电话号码:+4524784580
- 邮箱:stine.vest.hansen@regionh.dk
研究联系人备份
- 姓名:Henriette Lose
- 电话号码:+4523311294
- 邮箱:henlo@halsnaes.dk
学习地点
-
-
-
Frederiksværk、丹麦、3300
- 招聘中
- Halsnæs Kommune
-
接触:
- Henriette Lose
- 电话号码:+4523311294
- 邮箱:henlo@halsnaes.dk
-
接触:
- Stine S Christensen
- 电话号码:+4524898299
- 邮箱:stisc@halsnaes.dk
-
-
参与标准
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
取样方法
研究人群
All adult citizens in the Municipality of Halsnæs diagnosed with type 2 diabetes, COPD, and/or heart disease who are offered a health programme provided by the municipality from May 2026 through August 2027 are eligible for the subproject.
The subproject is tailored to the individual citizen's capacities and needs, and citizens who cannot or do not wish to participate in parts of the data collection will be included in the other project components to the extent that they wish and are able to. There are therefore no requirements for participation regarding language proficiency or the ability to attend in person, and the project staff will have the option of visiting citizens in their homes if they so wish. Accordingly, there are no exclusion criteria for participation.
描述
Inclusion Criteria:
- Diagnosis of type 2 diabetes, chronic obstructive pulmonary disease, or cardiovascular disease
- At or above 18 years of age
- Offered a health programme provided by Halsnæs Municipality
Exclusion Criteria:
- None
学习计划
研究是如何设计的?
设计细节
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Functional capacity
大体时间:From the start of a health intervention programme to the end of the health intervention programme (at 5-25 weeks).
|
To assess functional capacity, combined repeated measurements of muscle strength and body function, health-related quality of life, as well as functioning and disability are combined, thereby enabling a comprehensive assessment of all domains in the International Classification of Functioning, Disability and Health (ICF).
These measurements are used to describe the participants' overall functional capacity before and after a health intervention programme, in order to assess whether functional capacity improves over time.
|
From the start of a health intervention programme to the end of the health intervention programme (at 5-25 weeks).
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Muscle strength and physical function
大体时间:From the start of a health intervention programme to the end of the health intervention programme (at 5-25 weeks).
|
The citizen's muscle strength and physical function are assessed before and after a health intervention programme using a 30-second sit-to-stand test.
|
From the start of a health intervention programme to the end of the health intervention programme (at 5-25 weeks).
|
|
Mental well-being (WHO-5)
大体时间:From the start of a health intervention programme to the end of the health intervention programme (at 5-25 weeks).
|
The The World Health Organization-Five Well-Being Index (WHO-5) is a self-report instrument measuring mental well-being.
It consists of five statements relating to the past two weeks.
Each statement is rated on a 6-point scale with scores of 0-5 points.
The raw score is calculated by totalling the scores on each of the five questions, where zero represents the worst and 25 represents the best possible mental well-being.
The score will be converted to a percentage score ranging from zero to 100 by multiplying the raw score by four.
|
From the start of a health intervention programme to the end of the health intervention programme (at 5-25 weeks).
|
|
Health and Disability (WHODAS 2.0)
大体时间:From the start of a health intervention programme to the end of the health intervention programme (at 5-25 weeks).
|
The World Health Organization Disability Assessment Schedule (WHODAS 2.0) provides a standardized method for measuring health and disability differences made by a given intervention.
The scores assigned to each of the items - "none" (1), "mild" (2) "moderate" (3), "severe" (4) and "extreme" (5) - are summed, giving a score range from 12 to 60, where higher scores indicate higher disability or loss of function.
|
From the start of a health intervention programme to the end of the health intervention programme (at 5-25 weeks).
|
|
Attendance at annual diabetes check-ups
大体时间:From the start of a health intervention programme to the end of the health intervention programme (at 5-25 weeks).
|
Proportion of participants who have attended an annual diabetes check-up prior to participation in the municipal health intervention programme, and change in attendance at annual check-ups from baseline to end of the programme, to assess whether participation is associated with improved adherence to recommended annual follow-up.
|
From the start of a health intervention programme to the end of the health intervention programme (at 5-25 weeks).
|
|
Redemption of prescribed diabetes medication
大体时间:From the start of a health intervention programme to the end of the health intervention programme (at 5-25 weeks).
|
Proportion of participants who redeem prescribed diabetes medications.
Change in the proportion of redeemed prescriptions from baseline to the end of the municipal health intervention programme is used to assess whether participation is associated with improved medication adherence.
|
From the start of a health intervention programme to the end of the health intervention programme (at 5-25 weeks).
|
|
Glycated hemoglobin (HbA1c)
大体时间:From the start of a health intervention programme to the end of the health intervention programme (at 5-25 weeks).
|
Finger-prick capillary blood samples for measurement of long-term blood glucose levels.
|
From the start of a health intervention programme to the end of the health intervention programme (at 5-25 weeks).
|
|
Systolic blood pressure
大体时间:From the start of a health intervention programme to the end of the health intervention programme (at 5-25 weeks).
|
Measured three times with an automated device.
|
From the start of a health intervention programme to the end of the health intervention programme (at 5-25 weeks).
|
|
Diastolic blood pressure
大体时间:From the start of a health intervention programme to the end of the health intervention programme (at 5-25 weeks).
|
Measured three times with an automated device.
|
From the start of a health intervention programme to the end of the health intervention programme (at 5-25 weeks).
|
|
Heart rate
大体时间:From the start of a health intervention programme to the end of the health intervention programme (at 5-25 weeks).
|
Measured three times with an automated blood pressure device.
|
From the start of a health intervention programme to the end of the health intervention programme (at 5-25 weeks).
|
合作者和调查者
调查人员
- 学习椅:Ulla Toft、Steno Diabetes Center Copenhagen
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
- Steno Tvaers, H-25054476
- H-25054476 (其他标识符:De Videnskabsetiske Komiteer for Region Hovedstaden)
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.